Long-Term Assets: The sum of all assets classified as non-current.
Ionis Pharmaceuticals, Inc. (IONS) had Long-Term Assets of $533.20M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$203.33M |
|
$-229.39M |
|
$7.96M |
|
$195.37M |
|
$417.79M |
|
$-214.46M |
|
$-13.46M |
|
$-227.92M |
|
$-228.71M |
|
$-229.39M |
|
$-229.39M |
|
$-229.39M |
|
$-230.18M |
|
$-214.46M |
|
$-210.82M |
|
160.01M |
|
160.01M |
|
$-1.43 |
|
$-1.35 |
|
| Balance Sheet Financials | |
$2.99B |
|
$123.05M |
|
|
Long-Term Assets |
$533.20M |
$3.52B |
|
$781.57M |
|
$1.35B |
|
$2.25B |
|
$3.03B |
|
$489.09M |
|
$489.09M |
|
$489.09M |
|
163.31M |
|
| Cash Flow Statement Financials | |
$-268.58M |
|
$-277.78M |
|
$675.84M |
|
$242.08M |
|
$372.26M |
|
$130.18M |
|
$133.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.83 |
|
-- |
|
-- |
|
0.73 |
|
3.64 |
|
96.09% |
|
-105.47% |
|
-105.47% |
|
-- |
|
-112.09% |
|
-112.82% |
|
$-320.03M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.79 |
|
3.08 |
|
29.24 |
|
-46.90% |
|
-46.90% |
|
-6.51% |
|
-12.49% |
|
$2.99 |
|
$-2.00 |
|
$-1.68 |
|